Defining a new era of oligonucleotides

Defining a new era of oligonucleotides

4

SEC Filing Details

Document Details

Form
Filing Date
Jun 1, 2018
Document Date
May 30, 2018
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Wave Life Sciences
Issuer
Wave Life Sciences Ltd.
Filer
Francis Chris